Molecular Infectious Disease Testing Market Poised for Strong Growth Through 2031
The global healthcare industry is undergoing a significant transformation as molecular diagnostics continue to reshape infectious disease detection and management. According to MarketsandMarkets, the global Molecular Infectious Disease Testing Market is projected to grow from USD 11.30 billion in 2026 to USD 19.09 billion by 2031, registering a robust CAGR of 11.1% during the forecast period. The report, titled “Molecular Infectious Disease Testing Market by Product & Service (Kits, Instruments), Type (Singleplex, Multiplex), Test Type (Lab, PoC), Disease (STD, Flu, GI, HAI), Technology (PCR, NGS), End User (Diagnostic Labs, Hospitals) – Global Forecast to 2031,” highlights the growing importance of molecular diagnostics in modern healthcare systems. As infectious diseases continue to evolve globally, healthcare providers, diagnostic laboratories, and public health agencies are increasingly relying on advanced molecular testing technologies for rapid, accurate, and reliabl...